Page 182 - Tata_Chemicals_yearly-reports-2019-20
P. 182

the future depreciation charge could be revised and           On initial recognition, all foreign currency
                      may have an impact on the profit of the future years.  transactions are recorded at exchange rates
                                                                         prevailing on the date of the transaction.
                2.3.3  Employee benefit obligations                      Monetary assets and liabilities, denominated in a
                        Employee benefit obligations are determined      foreign currency, are translated at the exchange
                      using  actuarial  valuations.  An  actuarial  valuation   rate prevailing on the Balance Sheet date and the
                      involves making various assumptions that may       resultant exchange gains or losses are recognised
                      differ from actual developments.  These include    in the Standalone Statement of Profit and Loss.
                      the estimation of the appropriate discount rate,
                      future salary increases and mortality rates. Due      2.5   Property, plant and equipment
                      to the complexities involved in the valuation           An item of property, plant and equipment (‘PPE’)
                      and its long-term nature, the employee benefit     is recognised as an asset if it is probable that the
                      obligation is highly sensitive to changes in these   future  economic  benefits  associated  with  the
                      assumptions. All assumptions are reviewed at each   item will flow to the Company and its cost can be
                      reporting date.                                    measured reliably. These recognition principles are
                                                                         applied  to  the  costs  incurred  initially  to  acquire
                2.3.4  Provisions and contingencies                      an item of PPE, to the pre-operative and trial run
                        From time to time, the Company is subject to     costs incurred (net of sales), if any and also to the
                      legal proceedings, the ultimate outcome of         costs incurred subsequently to add to, replace part
                      each being subject to uncertainties inherent       of, or service it and subsequently carried at cost
                      in litigations. A provision for litigation is made   less accumulated depreciation and accumulated
                      when  it  is  considered  probable  that  a  payment   impairment losses, if any.
                      will be made and the amount can be reasonably
                      estimated. Significant judgement is required when           The cost of PPE includes interest on borrowings
                      evaluating the provision including, the probability   directly attributable to the acquisition, construction
                      of an unfavorable outcome and the ability to make   or production of a qualifying asset. A qualifying asset
                      a reasonable estimate of the amount of potential   is an asset that necessarily takes a substantial period
                      loss. Provisions for litigations are reviewed at each   of time to be made ready for its intended use or
                      accounting period and revisions made for the       sale. Borrowing costs and other directly attributable
                      changes  in  facts  and  circumstances.  Contingent   cost are added to the cost of those assets until such
                      liabilities are disclosed in the notes forming part of   time as the assets are substantially ready for their
                      the Standalone Financial Statements. Contingent    intended use, which generally coincides with the
                      assets are not disclosed in the Standalone Financial   commissioning date of those assets.
                      Statements unless an inflow of economic benefits
                      is probable.                                         The present value of the expected cost for the
                                                                         decommissioning  of  an  asset  after  its  use  is
                2.3.5   Impairment of investment in subsidiaries and     included in the cost of the respective asset if the
                      goodwill                                           recognition criteria for a provision is met.
                        The Company reviews its  carrying  value  of           Machinery spares that meet the definition of PPE
                      investment in subsidiaries and goodwill carried at   are capitalised and depreciated over the useful life
                      cost (net of impairment, if any) annually, or more   of the principal item of an asset.
                      frequently when there is indication for impairment.
                      If the recoverable amount is less than its carrying           All other repair and maintenance costs, including
                      amount, the impairment loss is accounted for in    regular servicing, are recognised in the Standalone
                      the Standalone Statement of Profit and Loss.
                                                                         Statement of Profit and Loss as incurred.  When
                                                                         a replacement occurs, the carrying value of the
                2.4   Foreign currency translation
                                                                         replaced part is de-recognised. Where an item of
                       The functional currency of the Company (i.e. the   property, plant and equipment comprises major
                      currency of the primary economic environment in    components having different useful lives, these
                      which the Company operates) is the Indian Rupee (`).  components are accounted for as separate items.



           180  I  INTEGRATED ANNuAL REPORT 2019-20
   177   178   179   180   181   182   183   184   185   186   187